Daiken Biomedical Co., Ltd. (TPE:7780)
13.95
-0.55 (-3.79%)
At close: Nov 19, 2026
| Market Cap | 11.24B -24.4% |
| Revenue (ttm) | 2.34B +31.2% |
| Net Income | 468.22M +74.3% |
| EPS | 0.58 +34.4% |
| Shares Out | 805.56M |
| PE Ratio | 24.10 |
| Forward PE | n/a |
| Dividend | 0.70 (5.01%) |
| Ex-Dividend Date | Dec 4, 2026 |
| Volume | 929,754 |
| Open | 14.40 |
| Previous Close | 14.50 |
| Day's Range | 13.95 - 14.55 |
| 52-Week Range | 13.80 - 29.40 |
| Beta | 0.45 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Mar 9, 2027 |